Company intelligence / Profile preview
Disruptive Pharma
Uppsala, Uppsala, Swedendisruptivepharma.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
Disruptive Pharma is developing improved drug formulations using its proprietary MMC technology, which enables amorphous stabilization of drugs to enhance solubility, bioavailability, and performance. The company’s lead program—an MMC-enhanced version of sorafenib targeting HCC and RCC—is expected to enter clinical trials in late 2024. The company also partners with other pharma companies to reformulate their APIs.
- Therapeutic areas
- Oncology
- Modalities
- Amorphous drug formulationsSmall molecules (focus on improving solubility and bioavailability of APIs via amorphous forms)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Notable partnerships include collaborations with pharmaceutical companies seeking improved API formulations.Also announced intent for a joint venture in Brazil related to health/wellness products through another entity called "Disruptive Pharma" focused on Latin America
Beyond the preview
Go deeper on Disruptive Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Disruptive Pharma.